---
schema_version: "secwatch.filing_event.v1"
accession: "0001093557-24-000024"
form_type: "8-K"
ticker: "DXCM"
cik: "0001093557"
company_name: "DEXCOM INC"
filed_at: "2024-02-15T23:59:59+00:00"
generated_at: "2026-06-06T00:43:15.527946+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# DexCom terminates warrants for 10.3M shares with Bank of America

## Summary
- Termination agreement with BofA on Feb 13, 2024, stops warrants covering 10.3M shares of common stock.
- Company will deliver shares to BofA based on 12-day VWAP averaging starting Feb 13, expected to finish in Q1 2024.
- Warrants were part of 2018 convertible note hedge transactions; JPM warrants remain outstanding.
- Shares issued under Section 4(a)(2) exemption; averaging period includes potential disruption adjustments.
- Agreement incorporates Rule 10b5-1 plan, permitting BofA to hedge during the averaging period.

## SEC filing metadata
- accession: 0001093557-24-000024
- form_type: 8-K
- ticker: DXCM
- cik: 0001093557
- company_name: DEXCOM INC
- filed_at: 2024-02-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 1.02, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1093557/000109355724000024/0001093557-24-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1093557/000109355724000024/dxcm-20240213.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001093557-24-000024
- JSON: https://secwatch.observer/filing/0001093557-24-000024.json
- Plain text: https://secwatch.observer/filing/0001093557-24-000024.txt

## Key facts
- Material Agreements
  DEXCOM INC entered into Termination Agreement with Bank of America, N.A. (effective 2024-02-13).
  - Action: entry
  - Counterparty: Bank of America, N.A.
  - Effective: 2024-02-13
  source text: On February 13, 2024, DexCom, Inc. (the “Company”) entered into a warrant termination agreement (the “Termination Agreement”) with Bank of America, N.A., (“BofA”), to terminate outstanding warrants to purchase shares of the Company’s common stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1093557/000109355724000024/0001093557-24-000024-index.htm
- Material Agreements
  DEXCOM INC terminated BofA Warrant Transactions with Bank of America, N.A. (effective 2024-02-13).
  - Action: termination
  - Counterparty: Bank of America, N.A.
  - Effective: 2024-02-13
  source text: Pursuant to the terms of the Termination Agreement, the BofA Warrant Transactions with respect to an aggregate of 10.3 million shares of Common Stock will be terminated.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1093557/000109355724000024/0001093557-24-000024-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.